SNIPR BIOME Announces U.S Food and Drug Administration grants Fast Track Designation for SNIPR001 for Prevention of Bloodstream Infections in Hematologic Cancer Patients

/PRNewswire/ -- SNIPR BIOME ApS, a leading CRISPR and microbiome biotechnology company, has been granted Fast Track designation by the U.S. Food and Drug...

Related Keywords

Germany ,Milan ,Lombardia ,Italy ,Denmark ,Copenhagen ,Køavn ,Munich ,Bayern ,United Kingdom ,Texas ,United States ,Amsterdam ,Noord Holland ,Netherlands , ,Twitter ,Boston University School Of Law ,National Institute Of Allergy ,University Of Texas Md Anderson Cancer ,Melinda Gates Foundation ,North East Family Office Copenhagen ,Wellcome ,Us Department Of Health ,United Kingdom Department Of Health ,Care Global Antimicrobial Resistance Innovation Fund ,Biomedical Advanced Research ,Human Services ,Drug Administration ,Boston University ,Development Authority ,Germany Federal Ministry Of Education ,United Kingdom Government Department Of Health ,Office Of The ,Life Sciences Partners Amsterdam ,Us National Institutes Of Health ,Novo Nordisk ,Fast Track ,New Drug ,Chief Medical Officer ,Life Sciences Partners ,North East Family Office ,Wellington Partners ,Assistant Secretary ,Federal Ministry ,United Kingdom Department ,Social Care ,Global Antimicrobial Resistance Innovation Fund ,United Kingdom Government Department ,National Institute ,Infectious Diseases ,Resistant Threats ,Priority Bacterial Pathogens ,Boston University School ,Snipr Biome Aps ,